Nitric oxide synthase inhibition impairs myocardial efficiency and ventriculo-arterial matching in acute ischemic heart failure

European Journal of Heart Failure

Volumn 6, Issue 6, 2004, Pages 705-713

  Nordhaug, Dag ^a,b   Steensrud, Tor ^a,b   Aghajani, Ebrahim ^b   Korvald, Christian ^b   Myrmel, Truls ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Energy metabolism; Heart failure; Hemodynamics; Nitric oxide; Ventricular function

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEMODYNAMICS; ISCHEMIC HEART DISEASE; LEFT CORONARY ARTERY; MALE; MEASUREMENT; MICROEMBOLISM; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; ENERGY METABOLISM; MALE; MYOCARDIAL ISCHEMIA; NITRIC OXIDE SYNTHASE; OXYGEN CONSUMPTION; RANDOM ALLOCATION; SWINE; VENTRICULAR FUNCTION, LEFT;

EID: 7944228274     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2003.11.010     Document Type: Article

References (40)

1. Hands M.E., Rutherford J.D., Muller J.E., Davies G., Stone P.H., Parker C., et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol. 14:(1):1989;40-46
2. Goldberg R.J., Gore J.M., Alpert J.S., Osganian V., de Groot J., Bade J., et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med. 325:(16):1991;1117-1122
3. Holmes D.R. Jr, Bates E.R., Kleiman N.S., Sadowski Z., Horgan J.H., Morris D.C., et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol. 26:(3):1995;668-674
4. Hochman J.S., Sleeper L.A., Webb J.G., Sanborn T.A., White H.D., Talley J.D., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 341:(9):1999;625-634
5. Goldberg R.J., Samad N.A., Yarzebski J., Gurwitz J., Bigelow C., Gore J.M. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 340:(15):1999;1162-1168
6. Flesch M., Kilter H., Cremers B., Lenz O., Sudkamp M., Kuhn-Regnier F., et al. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmacol Exp Ther. 281:(3):1997;1340-1349
7. Paulus W.J. The role of nitric oxide in the failing heart. Heart Fail Rev. 6:(2):2001;105-118
8. Drexler H., Kastner S., Strobel A., Studer R., Brodde O.E., Hasenfuss G. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol. 32:(4):1998;955-963
9. Node K., Kitakaze M., Yoshihara F., Sasaki T., Kuzuya T., Hori M. Increased cardiac levels of nitric oxide in patients with chronic heart failure. Am J Cardiol. 86:(4):2000;474-477
10. Node K., Kitakaze M., Sato H., Koretsune Y., Karita M., Kosaka H., et al. Increased release of nitric oxide in ischemic hearts after exercise in patients with effort angina. J Am Coll Cardiol. 32:(1):1998;63-68
11. O'Murchu B., Miller V.M., Perrella M.A., Burnett J.C. Jr. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest. 93:(1):1994;165-171
12. Cotter G., Kaluski E., Blatt A., Milovanov O., Moshkovitz Y., Zaidenstein R., et al. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. Circulation. 101:(12):2000;1358-1361
13. Suto N., Mikuniya A., Okubo T., Hanada H., Shinozaki N., Okumura K. Nitric oxide modulates cardiac contractility and oxygen consumption without changing contractile efficiency. Am J Physiol. 275:(1 Pt 2):1998;H41-H49
14. Shen W., Xu X., Ochoa M., Zhao G., Wolin M.S., Hintze T.H. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 75:(6):1994;1086-1095
15. Heusch G., Post H., Michel M.C., Kelm M., Schulz R. Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res. 87:(2):2000;146-152
16. Datta P., Magder S. Hemodynamic response to norepinephrine with and without inhibition of nitric oxide synthase in porcine endotoxemia. Am J Respir Crit Care Med. 160:(6):1999;1987-1993
17. Glower D.D., Spratt J.A., Snow N.D., Kabas J.S., Davis J.W., Olsen C.O., et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation. 71:(5):1985;994-1009
18. Suga H. Ventricular energetics. Physiol Rev. 70:(2):1990;247-277
19. Baan J., van der Velde E.T., de Bruin H.G., Smeenk G.J., Koops J., van Dijk A.D., et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation. 70:(5):1984;812-823
20. Nordhaug D., Steensrud T., Korvald C., Aghajani E., Myrmel T. Preserved myocardial energetics in acute ischemic heart failure-studies in an experimental pig model. Eur J Cardiothorac Surg. 22:(1):2002;135-142
21. Cotton J.M., Kearney M.T., MacCarthy P.A., Grocott-Mason R.M., McClean D.R., Heymes C., et al. Effects of nitric oxide synthase inhibition on Basal function and the force-frequency relationship in the normal and failing human heart in vivo. Circulation. 104:(19):2001;2318-2323
22. Mohan P., Brutsaert D.L., Paulus W.J., Sys S.U. Myocardial contractile response to nitric oxide and cGMP. Circulation. 93:(6):1996;1223-1229
23. Heymes C., Vanderheyden M., Bronzwaer J.G., Shah A.M., Paulus W.J. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation. 99:(23):1999;3009-3016
24. Hare J.M., Givertz M.M., Creager M.A., Colucci W.S. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. Circulation. 97:(2):1998;161-166
25. Fukuchi M., Hussain S.N., Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy. Circulation. 98:(2):1998;132-139
26. Drexler H. Nitric oxide synthases in the failing human heart: a doubled-edged sword? Circulation. 99:(23):1999;2972-2975. editorial; comment
27. Kojda G., Kottenberg K. Regulation of basal myocardial function by NO. Cardiovasc Res. 41:(3):1999;514-523
28. Thielmann M., Dorge H., Martin C., Belosjorow S., Schwanke U., van De S.A., et al. Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor- alpha, and sphingosine. Circ Res. 90:2002;807-813
29. Paulus W.J., Vantrimpont P.J., Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation. 89:(5):1994;2070-2078
30. Recchia F.A., McConnell P.I., Bernstein R.D., Vogel T.R., Xu X., Hintze T.H. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res. 83:(10):1998;969-979. see comments
31. Burkhoff D., Sagawa K. Ventricular efficiency predicted by an analytical model. Am J Physiol. 250:(6 pt 2):1986;R1021-R1027
32. Abe K., Hayashi N., Terada H. Effect of endogenous nitric oxide on energy metabolism of rat heart mitochondria during ischemia and reperfusion. Free Radic Biol Med. 26:(3-4):1999;379-387
33. Xie Y.W., Shen W., Zhao G., Xu X., Wolin M.S., Hintze T.H. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res. 79:(3):1996;381-387
34. Riobo N.A., Clementi E., Melani M., Boveris A., Cadenas E., Moncada S., et al. Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem J. 359:(Pt 1):2001;139-145
35. Shinke T., Takaoka H., Takeuchi M., Hata K., Kawai H., Okubo H., et al. Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy. Circulation. 101:(16):2000;1925-1930
36. Chen Y., Traverse J.H., Du R., Hou M., Bache R.J. Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation. 106:(2):2002;273-279
37. Landry D.W., Oliver J.A. The pathogenesis of vasodilatory shock. N Engl J Med. 345:(8):2001;588-595
38. Keaney J.F. Jr, Hare J.M., Balligand J.L., Loscalzo J., Smith T.W., Colucci W.S. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. Am J Physiol. 271:(6 pt 2):1996;H2646-H2652
39. Erbel R., Heusch G. Coronary microembolization-its role in acute coronary syndromes and interventions. Herz. 24:(7):1999;558-575
40. Erbel R., Heusch G. Spontaneous and iatrogenic microembolization. A new concept for the pathogenesis of coronary artery disease. Herz. 24:(7):1999;493-495. editorial